These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 95160)

  • 41. [Clinical evaluation of the effectiveness and stability of action of sustained-release disopyramide phosphate by the Holter method].
    de Lombera Romero F; Martínez-Osorio Corzan L; Seoane J; Franco JR
    Rev Esp Cardiol; 1985; 38(6):446-50. PubMed ID: 2419948
    [No Abstract]   [Full Text] [Related]  

  • 42. Disopyramide: a new agent for effective therapy of ventricular dysrhythmias.
    Mason DT
    Drugs; 1978 May; 15(5):329-30. PubMed ID: 657990
    [No Abstract]   [Full Text] [Related]  

  • 43. [Action of injectable disopyramide phosphate in the emergency treatment of ventricular tachycardia].
    Valère PE; Guerot C; Castillo Fenoy A; Branvin E; Urbanczyk A; Tricot R
    Coeur Med Interne; 1977; 16(2):285-92. PubMed ID: 891126
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical studies of Norpace (Part II).
    Vismara L
    Angiology; 1975 Jan; 26(1 Pt 2):132-6. PubMed ID: 1090213
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical results of pyridinolcarbamate treatment of chronic Chagas' heart disease].
    Vieira E
    Rev Bras Med; 1972 Mar; 29(3):145-7. PubMed ID: 4624419
    [No Abstract]   [Full Text] [Related]  

  • 46. [The use of a temporary pacemaker in the therapy of refractory ventricular arrhythmias].
    Ping WC; Carneiro L; de Carvalho ET; Chaui AF; Hironaka F; Arie S; Pileggi F; Décourt LV
    Rev Hosp Clin Fac Med Sao Paulo; 1979 Feb; 34(1):10-5. PubMed ID: 112660
    [No Abstract]   [Full Text] [Related]  

  • 47. Efficacy of disopyramide phosphate in the treatment of refractory ventricular arrhythmias.
    Meyers DG; Mohiuddin SM
    Nebr Med J; 1980 May; 65(5):123-5. PubMed ID: 7383223
    [No Abstract]   [Full Text] [Related]  

  • 48. [Multicenter comparative studies of the effectiveness and tolerance of propafenone and disopyramide in the treatment of premature ventricular beats].
    Lukasik S; Nowosad H; Grzelak H; Kowalewski W; Kowalisko A
    Pol Arch Med Wewn; 1987 Jun; 77(6):291-9. PubMed ID: 2482478
    [No Abstract]   [Full Text] [Related]  

  • 49. [Efficacy of disopyramide and mexiletine per os in the chronic treatment of ventricular arrhythmias sensitive to lidocaine].
    Ricciardelli B; Volpe M; De Luca N; D'Ascia C; Bonaduce D; Trimarco B; Rengo F; Condorelli M
    Boll Soc Ital Cardiol; 1981; 26(2):139-44. PubMed ID: 7337769
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of disopyramide and aprindine on arrhythmias after acute myocardial infarction.
    Pouleur H; Chaudron JM; Reyns P
    Eur J Cardiol; 1977 Jul; 5(5):397-404. PubMed ID: 330168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of chronic ventricular extrasystole with propafenone (Rhythmonorm)].
    Dimitrov D
    Vutr Boles; 1984; 23(4):65-9. PubMed ID: 6209861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical experience with disopyramide.
    Sequeira M; Luria MH
    Ohio State Med J; 1979 Feb; 75(2):67-9. PubMed ID: 424144
    [No Abstract]   [Full Text] [Related]  

  • 53. Disopyramide induced hypoglycemia.
    Turtzo DF; Ghatak PK
    Pa Med; 1986 May; 89(5):34-6. PubMed ID: 2425329
    [No Abstract]   [Full Text] [Related]  

  • 54. [Evaluation of propafenon in Chagas patients with ventricular extrasystole].
    da Silva MA; Fragata Filho AA; Boainain E; Magalhães HM
    Arq Bras Cardiol; 1981 Jun; 36(6):437-40. PubMed ID: 6180714
    [No Abstract]   [Full Text] [Related]  

  • 55. [Supraventricular paroxysmal tachycardia with aberrant conduction in a patient with Chagas' disease. Report of a case].
    Mello DC; Alencar SM; Trigueiros JC; Carvalho S; Cavalcante E; Albuquerque C; Loureiro FB
    Arq Bras Cardiol; 1977 Jun; 30(3):217-20. PubMed ID: 411460
    [No Abstract]   [Full Text] [Related]  

  • 56. [Theoretical suppositions and clinical use of verapamil in the treatment of ventricular extrasystole in acute myocardial infarct].
    Buttafarro A; Pavia L; Siracusano L; Freni F; Bitto U; Casella G
    Boll Soc Ital Cardiol; 1978; 23(2):317-21. PubMed ID: 89852
    [No Abstract]   [Full Text] [Related]  

  • 57. More about premature ventricular complexes.
    Turakhia DP
    J Assoc Physicians India; 1990 Sep; 38(9):670. PubMed ID: 1702417
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical studies of Norpace (Part IV).
    Jutzy RV
    Angiology; 1975 Jan; 26(1 Pt 2):138-9. PubMed ID: 803798
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical studies of Norpace (Part I).
    Smith WS
    Angiology; 1975 Jan; 26(1 Pt 2):124-31. PubMed ID: 1090212
    [No Abstract]   [Full Text] [Related]  

  • 60. [When should ventricular extrasystole be treated?].
    Hoffmann A
    Schweiz Rundsch Med Prax; 1985 Jan; 74(1-2):1-2. PubMed ID: 2578687
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.